| Cerner Primary Mnemonic: | OnkoSight Advanced NGS MPN Panel |
| PDM | 245349 |
| Informatics - Workgroup | Molecular-Send Outs |
| Synonyms * | OSA NGS MPN |
| Display Name * | OnkoSight Advanced NGS MPN Panel |
| Specimen Sources (combined Order Entry and Specimen Navigator) * |
Blood, Arterial
Blood, Capillary
Blood, Central Line
Blood, Venous
|
| Specimen Types (combined Order Entry and Specimen Navigator) * |
Blood
|
| Body Fluids (types sent through AOEs) |
|
| Specimen Navigator Specimen Types |
|
| Specimen Navigator Specimen Sources |
|
| Specimen Navigator Short Name | |
| Ordering info (EPIC SmartText) | Clinical Utility Tumor sequencing by NGS detecting mutations in 17 genes associated with MPN. Mutations often have prognostic significance, may confer resistance to FDA approved therapies, or may qualify patients for late-stage clinical trials.
Gene content:
ABL1
ASXL1
CALR
CBL
CSF3R
DNMT3A
EZH2
IDH1
IDH2
JAK2
KIT
MPL
SETBP1
SF3B1
SRSF2
TP53
U2AF1 |
| IP Orderable (inpatient) | Yes |
| OP Orderable (outpatient) | Yes |
AOEs *
|
| AP AOEs | |
| Special History | No |
| Build Comments | |
| Filter * | |
| Cerner Site Restrict | Bio Reference Laboratory
BioReference Health LLC
LabCorp
Northwell Health Laboratories |
Cerner Results
| Result Desc |
Result display |
Result PDM |
| References 2 |
References 2 |
237540J |
| References 1 |
References 1 |
237540I |
| Clinical trials 2 |
Clinical trials 2 |
237540F |
| Therapeutic and Prognostic Associations |
Therapeutic and Prognostic Associations |
237540A |
| Allele Frequencies: |
Allele Frequencies: |
237540M |
| OnkoSight Advanced NGS MPN Panel |
OSA NGS MPN |
245349A |
| Interpretation summary |
Interpretation summary |
237540B |
| Addendum |
Addendum |
237540L |
| Detailed genetic interpretation 1 |
Detailed genetic interpretation 1 |
237540C |
| Detailed genetic interpretation 2 |
Detailed genetic interpretation 2 |
237540D |
| Clinical trials 1 |
Clinical trials 1 |
237540E |
| Methods: |
Methods: |
237540H |
| Report footer |
Report footer |
237540K |
|
| PROCEDURE ID |
192061 |
| PDM |
245349 |
| ORDER DISPLAY NAME |
OnkoSight Advanced NGS MPN Panel |
| PROCEDURE NAME |
ONKOSIGHT ADVANCED NGS MPN PANEL |
| PROCEDURE MASTER NUMBER |
LAB4194 |
| SHORT PROCEDURE NAME |
ONKOSIGHT ADVANCED NGS MPN PANEL |
| CATEGORY CODE |
21.0 |
| CATEGORY CODE RECORD NAME |
LAB MOLECULAR DIAGNOSTICS ORDERABLES |
| SYNONYMS |
OSA NGS MPN |
| CLINICALLY ACTIVE |
Yes |
| ORDERABLE |
Yes |
| PERFORMABLE |
Yes |
| FILTER GENOMICS |
Generic Genomics Procedure |
| REFERENCE LINK URL |
https://labs.northwell.edu/epic/test/192061 |
| ORDERING INSTRUCTIONS |
|
| DEFAULT SPECIMEN TYPE |
Blood |
| SPECIMEN TYPE PICK LIST |
Blood |
| SPECIMEN TYPE LIST |
Blood |
| OP SPECIMEN TYPE LIST |
|
| SPECIMEN SOURCE PICK LIST |
Blood, Arterial
Blood, Capillary
Blood, Central Line
Blood, Venous |
| SPECIMEN SOURCE DEFAULT - MALE |
Blood, Venous |
| SPECIMEN SOURCE DEFAULT - FEMALE |
Blood, Venous |
| SPECIMEN SOURCE LIST |
|
| OP SPECIMEN SOURCE LIST |
|
| IP LAB TEST COMPONENTS FOR REPORT |
ADDENDUM
ALLELE
CLINTRIAL
DETAILGENINT
METHODS
ONKONGSMPN
ONKOSIGHTINT
REF1
REF2
RPTFOOTER
SPECAPPEAR
THERPROGASS |
| OP LAB TEST COMPONENTS FOR REPORT |
ADDENDUM
ALLELE
CLINTRIAL
DETAILGENINT
METHODS
ONKONGSMPN
ONKOSIGHTINT
REF1
REF2
RPTFOOTER
SPECAPPEAR
THERPROGASS |
| ORDER QUESTIONS |
["3045300170", "3045300171", "3045300173"] |
| ORDER QUESTIONS RECORD NAME |
NH IP HOME COLLECT DATE
NH IP HOME COLLECT DAYS
NH IP HOME COLLECT MEDICALLY NECESSARY |
| INPATIENT ORDER QUESTIONS |
[] |
| INPATIENT ORDER QUESTIONS RECORD NAME |
|
| ORDER SPECIFIC QUESTION OVERRIDE |
Yes |
| INPATIENT QUESTION OVERRIDE |
Yes |
| LOCATION RESTRICT LIST IP |
|
| LOCATION RESTRICT LIST IP RECORD NAME |
|
| LOCATION RESTRICT LIST INCLUDE IP |
|
| LOCATION RESTRICT LIST OP |
|
| LOCATION RESTRICT LIST OP RECORD NAME |
|
| LOCATION RESTRICT LIST INCLUDES OP |
|
| EDP AMB ORDER SPECIFIC QUESTIONS RECORD NAME |
NH IP PATIENT COMPLETED CONSENT |
| EDP IP ORDER SPECIFIC QUESTIONS RECORD NAME |
NH IP PATIENT COMPLETED CONSENT |
| EDP IP SPECIMEN SOURCE |
|
| EDP OP SPECIMEN SOURCE |
|
| EDP IP SPECIMEN TYPE |
|
| EDP OP SPECIMEN TYPE |
|
| DERIVED EDP IP BUTTONS S |
|
| DERIVED EDP IP BUTTONS T |
|
| DERIVED EDP OP BUTTONS S |
|
| DERIVED EDP OP BUTTONS T |
|
| IP ORDERABLE |
1 |
| OP ORDERABLE |
1 |
| STANDARD LAB COMPONENTS |
|
| STANDARD LAB COMPONENTS RECORD NAME |
|
| COMPONENT DATA REQUIREMENT |
|
EPIC OP AOEs
| Question ID | Question Name | Question | Response Type | Response List | Require Response |
|---|
| 3045300170 |
NH IP HOME COLLECT DATE |
Start Date |
Date |
|
Yes |
| 3045300171 |
NH IP HOME COLLECT DAYS |
Days |
Custom List |
Monday
Tuesday
Wednesday
Thursday
Friday
Saturday
Sunday |
Yes |
| 3045300173 |
NH IP HOME COLLECT MEDICALLY NECESSARY |
Medically Necessary? |
Yes/No |
|
Yes |
|
EPIC IP AOEs
|
EPIC Components (results - crosswalked through Cerner)
| Component ID | Component Name | Base Name | Common Name | External Name | Cerner Result PDM |
|---|
| 3047804494.0 |
REFERENCES 2 |
REF2 |
REFERENCES 2 |
References 2 |
237540J |
| 3047804493.0 |
REFERENCES 1 |
REF1 |
REFERENCES 1 |
References 1 |
237540I |
| 3047801845.0 |
CLINICAL TRIALS 2 : |
CLINTRIAL |
CLINICAL TRIALS 2 |
Clinical Trials 2: |
237540F |
| 3047804957.0 |
THERAPEUTIC AND PROGNOSTIC ASSOCIATIONS |
THERPROGASS |
THERAPEUTIC AND PROGNOSTIC ASSOCIATIONS |
Therapeutic and Prognostic Associations |
237540A |
| 3047800914.0 |
ALLELE FREQUENCIES: |
ALLELE |
ALLELE FREQUENCIES |
Allele Frequencies: |
237540M |
| 3047808380.0 |
ONKOSIGHT ADVANCED NGS MPN PANEL |
ONKONGSMPN |
ONKOSIGHT ADVANCED NGS MPN PANEL |
OnkoSight Advanced NGS MPN Panel |
245349A |
| 3047803091.0 |
INTERPRETATION SUMMARY |
ONKOSIGHTINT |
INTERPRETATION SUMMARY |
Interpretation Summary |
237540B |
| 3047800865.0 |
ADDENDUM : |
ADDENDUM |
ADDENDUM |
Addendum: |
237540L |
| 3047802136.0 |
DETAILED GENETIC INTERPRETATION 1 |
DETAILGENINT |
DETAILED GENETIC INTERPRETATION 1 |
Detailed Genetic Interpretation 1 |
237540C |
| 3047802137.0 |
DETAILED GENETIC INTERPRETATION 2 : |
DETAILGENINT |
DETAILED GENETIC INTERPRETATION 2 |
Detailed Genetic Interpretation 2 : |
237540D |
| 3047801844.0 |
CLINICAL TRIALS 1 : |
CLINTRIAL |
CLINICAL TRIALS 1 |
Clinical Trials 1: |
237540E |
| 3048100148.0 |
METHODS |
METHODS |
METHODS |
Methods |
237540H |
| 3048100147.0 |
REPORT FOOTER |
RPTFOOTER |
REPORT FOOTER |
Report Footer |
237540K |
|
